Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction

To study the role of the CD40-CD40 ligand interaction in the development of memory B cells and its level of action during primary antibody responses in vivo, mice were injected with a soluble CD40 fusion protein (sCD40-gamma 1), so as to block the interaction. The effects of the treatment on the primary antibody response were reminiscent of hyper-immunoglobulin M (IgM) syndrome (HIMG1): antigen- specific IgG responses were grossly inhibited whereas the IgM response was augmented severalfold. The latter observation suggests that there is a T-dependent, CD40 ligand-independent pathway of B cell activation that leads to IgM responses and that a significant component of the IgM in HIMG1 patients is derived from T-dependent responses. The secondary response was not readily blocked by sCD40-gamma 1 treatment, indicating a relative independence of CD40 ligation of antigen-experienced B cells. The most striking finding from these studies is that the development of memory B cell populations (measured by adoptive transfer) is grossly impaired by administration of sCD40-gamma 1 during the early induction phase of the response. It is surprising that although the generation memory is diminished, there is no quantitative difference in the development of germinal centers. Whereas entry of B cells into the memory cell pathway is dependent on CD40 ligation, the clonal expansion of the potential memory precursors in germinal centers seems not to require a CD40 signal.

[1]  R. Noelle,et al.  Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells. , 1989, Journal of immunology.

[2]  I. Maclennan,et al.  Marginal zones: the major B cell compartment of rat spleens , 1981, European journal of immunology.

[3]  B. Hausmann,et al.  B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes , 1993, The Journal of experimental medicine.

[4]  L. Herzenberg,et al.  Localization of murine Ig-1b and Ig-1a (IgG 2a) allotypic determinants detected with monoclonal antibodies. , 1979, Molecular immunology.

[5]  P. Lipsky,et al.  Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells. , 1991, Journal of immunology.

[6]  R. Noelle,et al.  Cognate interactions between helper T cells and B cells. V. Reconstitution of T helper cell function using purified plasma membranes from activated Th1 and Th2 T helper cells and lymphokines. , 1991, Journal of immunology.

[7]  A. Aruffo,et al.  gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory , 1994, The Journal of experimental medicine.

[8]  C. Maliszewski,et al.  Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion , 1992, The Journal of experimental medicine.

[9]  J. Schröder,et al.  Activation to IgG secretion by lipopolysaccharide requires several proliferation cycles. , 1979, Journal of immunology.

[10]  E. C. Snow,et al.  Cognate interactions between helper T cells and B cells. , 1990, Immunology today.

[11]  D. Gray,et al.  Virgin B cell recruitment and the lifespan of memory clones during antibody responses to 2,4‐dinitrophenyl‐hemocyanin , 1986, European journal of immunology.

[12]  C. Smith,et al.  A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. , 1990, Science.

[13]  P. Linton,et al.  Primary antibody-forming cells and secondary B cells are generated from separate precursor cell subpopulations , 1989, Cell.

[14]  H. Mitsuya,et al.  Evidence for the failure of IgA specific T helper activity in a patient with immunodeficiency with hyper IgM. , 1979, Journal of clinical & laboratory immunology.

[15]  G. Guy,et al.  Synergistic interaction between interleukin 4 and anti‐Bp50 (CDw40) revealed in a novel B cell restimulation assay , 1987, European journal of immunology.

[16]  A. Aruffo,et al.  In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions , 1993, The Journal of experimental medicine.

[17]  H. Müller-Eberhard,et al.  DEFICIENCY OF THE FIFTH COMPONENT OF COMPLEMENT IN MICE WITH AN INHERITED COMPLEMENT DEFECT , 1967, The Journal of experimental medicine.

[18]  J. Bajorath,et al.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome , 1993, Cell.

[19]  J. Banchereau,et al.  Activation of human B lymphocytes through CD40 and interleukin 4 , 1989, European journal of immunology.

[20]  P. Pereira,et al.  T Cell‐Dependent B Cell Activation , 1984, Immunological reviews.

[21]  R. Coffman,et al.  Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. , 1990, Journal of immunology.

[22]  Andrew H. Liu,et al.  DEFECTIVE EXPRESSION OF T-CELL CD40 LIGAND CAUSES X-LINKED IMMUNODEFICIENCY WITH HYPER IgM , 1994, Pediatrics.

[23]  H. Spits,et al.  CD40 is functionally expressed on human thymic epithelial cells. , 1992, Journal of immunology.

[24]  E. Clark,et al.  Soluble forms of CD40 inhibit biologic responses of human B cells. , 1992, Journal of immunology.

[25]  A. Fischer,et al.  CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM , 1993, Nature.

[26]  M. Cooper,et al.  The T cell dependence of B cell differentiation induced by pokeweed mitogen. , 1976, Journal of immunology.

[27]  A. Aruffo,et al.  In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39 , 1993, The Journal of experimental medicine.

[28]  I. Maclennan,et al.  Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis , 1991, European journal of immunology.

[29]  I. Stamenkovic,et al.  Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Stein,et al.  Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease , 1992, Cell.

[31]  G. Kelsoe,et al.  In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations , 1991, The Journal of experimental medicine.

[32]  M. Cooper,et al.  Hyper IgM immunodeficiency. A primary dysfunction of B lymphocyte isotype switching. , 1983, The Journal of clinical investigation.

[33]  R. Geha,et al.  Hyper immunoglobulin M immunodeficiency. (Dysgammaglobulinemia). Presence of immunoglobulin M-secreting plasmacytoid cells in peripheral blood and failure of immunoglobulin M-immunoglobulin G switch in B-cell differentiation. , 1979, The Journal of clinical investigation.

[34]  David Gray,et al.  Expansion, Selection and Mutation of Antigen‐Specific B Cells in Germinal Centers , 1992, Immunological reviews.

[35]  Klaus Rajewsky,et al.  Intraclonal generation of antibody mutants in germinal centres , 1991, Nature.

[36]  K. Rajewsky,et al.  Expansion and functional activity of Ly‐1+ B cells upon transfer of peritoneal cells into allotype‐congenic, newborn mice , 1987, European journal of immunology.

[37]  I. Stamenkovic,et al.  A B‐lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. , 1989, The EMBO journal.

[38]  D. Gray,et al.  Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes , 1992, European journal of immunology.

[39]  H. Karasuyama,et al.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.

[40]  H. Ochs,et al.  B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells , 1993, The Journal of experimental medicine.

[41]  J. Banchereau,et al.  Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. , 1991, Science.

[42]  R. Coffman,et al.  Mechanism and regulation of immunoglobulin isotype switching. , 1993, Advances in immunology.

[43]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[44]  I. Stamenkovic,et al.  The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity. , 1992, The EMBO journal.

[45]  E. Clark,et al.  Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.